Few people know but this drug could increase the risk of breast cancer

There is little doubt that the legalization of the contraceptive pill in Italy has changed the lives of millions of women. Still, using this drug could have unwanted consequences for women’s health. In fact, few people know but this drug could increase the risk of contracting breast cancer. In this article, we will analyze the connection between taking this drug and the onset of certain pathologies. Before starting, it is important to remember that the data used for this article is also reported by the well-known research foundation AIRC.

Birth control pills and breast cancer

There are various scientific studies that have shown a possible link between taking oral contraceptives and an increased risk of developing breast cancer. Today we will analyze one of these scientific studies also proposed by the AIRC. In 2017, a Danish study dedicated to the subject was published in a well-known English magazine. This research considered 1.8 million women for an average of 10.9 years. According to this study, women who took oral contraceptives had a relative risk of developing breast cancer that was about 20% higher. The type of drug used and the time of intake also affect the likelihood of incurring the disease.

Few people know but this drug could increase the risk of breast cancer

However, taking oral contraceptives could also protect women from the risk of incurring certain types of cancer. In fact, women who took these medicines would have a lowered average relative risk of developing endometrial cancer by 30%. The protective effect of the pill would be linked to the timing of taking it and would persist even many years after you have stopped taking it. Taking these medicines would also lead to a lowering of the relative risk of developing ovarian cancer by 30-50%. This factor would persist even after 30 years from taking this drug. Finally, the use of oral contraceptives would lead to a reduction in the risk of getting colorectal cancer by an average of 15-20%.

In conclusion, it is important that the data reported relate to studies that have analyzed the consequences of using the combined pill. Furthermore, as reported by the AIRC, it is important to underline that these researches refer to patients who may have used compounds different from those still on the market. For this reason, these results may not be referable to medicines currently distributed.

Deepening:

How to prevent cancer by following these simple expert tips